Hale Akpinar
Overview
Explore the profile of Hale Akpinar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuzuguldu R, Sagol O, Unlu M, Keskinkilic M, Derici S, Akpinar H, et al.
Turk J Gastroenterol
. 2025 Jan;
PMID: 39840863
Background/aims: Accurately determining the human epidermal growth factor receptor 2 (HER2) status is crucial in identifying suitable candidates for targeted therapy in gastric cancer, considering the cost and potential side...
2.
Sezgin O, Akpinar H, Ozer B, Toruner M, Bal K, Bor S
Turk J Gastroenterol
. 2023 Jun;
34(6):652-664.
PMID: 37303246
Background: There is limited data about the prevalence of frequent gastrointestinal diseases in developing parts of the world based on community-based screening studies. Therefore, we aimed to present the detailed...
3.
Huseynzada S, Yuce Inel T, Hajiyev F, Koken Avsar A, Balci A, Akpinar H, et al.
Eur J Rheumatol
. 2023 May;
10(2):50-56.
PMID: 37171478
Objective: Vedolizumab is a novel anti-inflammatory molecule that is currently being used in the treatment of refractory inflammatory bowel disease. The mode of action is inhibiting the binding of activated...
4.
Sezgin E, Terlemez G, Bozkurt B, Bengi G, Akpinar H, Buyuktorun I
PeerJ
. 2022 Oct;
10:e14217.
PMID: 36275453
Inflammatory bowel diseases (IBD) affect millions of people worldwide with increasing incidence. Ulcerative colitis (UC) and Crohn's disease (CD) are the two most common IBDs. There is no definite cure...
5.
Savarino E, Zingone F, Barberio B, Marasco G, Akyuz F, Akpinar H, et al.
United European Gastroenterol J
. 2022 Jun;
10(6):556-584.
PMID: 35695704
Irritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. In spite of their high prevalence, IBS-D and FDr are...
6.
Toruner M, Basaranoglu M, Atug O, Senturk O, Akyuz F, Cekic C, et al.
Turk J Gastroenterol
. 2022 Jun;
33(5):406-413.
PMID: 35678798
Background: Patients with Crohn's disease experience major deterioration in work productivity and quality of life. We aimed to provide the long-term effects of anti-tumor necrosis factor agents on work productivity...
7.
Ozdinc S, Akpinar H, Bengi G, Sarioglu S, Sagol O, Dervis Hakim G, et al.
Croat Med J
. 2021 Nov;
62(5):435-445.
PMID: 34730883
Aim: To determine which flexible spectral imaging color enhancement (FICE) channel best visualizes colon mucosa in ulcerative colitis (UC) and to compare FICE imaging with standard imaging. Methods: The study...
8.
Turan B, Bengi G, Cehreli R, Akpinar H, Soyturk M
World J Clin Cases
. 2021 Oct;
9(25):7417-7432.
PMID: 34616808
Background: There are various studies showing the relationship between irritable bowel syndrome (IBS) and diet, and some dietary adjustments are recommended to reduce symptoms. In recent years, there is a...
9.
Gokcekuyu B, Yilmaz O, Soyturk M, Ellidokuz H, Akpinar H, Simsek I
Turk J Gastroenterol
. 2021 Jun;
32(3):269-275.
PMID: 34160356
Background: It is known that clarithromycin resistance has increased over the years (success rate 60%). The aim of the study was to investigate the importance of regional antimicrobial resistance rates...
10.
Hazir-Konya H, Avkan-Oguz V, Akpinar H, Sagol O, Sayiner A
Turk J Gastroenterol
. 2021 May;
32(2):123-132.
PMID: 33960935
Background: In Turkey, cytomegalovirus (CMV) seropositivity has been reported to be high, between 85 and 100%. CMV has been responsible for disease exacerbation in inflammatory bowel disease (IBD). We aimed...